Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer.
Denis
L
L
Vrije Universiteit Brussels-AZ Middelheim, Department of Urology, Antwerp, Belgium.
Murphy
G P
GP
D000726:Androgen Antagonists / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017326:Clinical Trials, Phase III as Topic; D003131:Combined Modality Therapy / Q000639:trends; D006801:Humans; D008297:Male; D009919:Orchiectomy; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000601:surgery
D000726:Androgen Antagonists; D000970:Antineoplastic Agents